CHA2DS2-VASc-HS Score as a Predictor of No-Reflow in Patients with ST-Segment Elevation Myocardial Infarction Who Underwent Primary Percutaneous Intervention
Al-Azhar International Medical Journal, Vol: 4, Issue: 9
2023
- 52Usage
- 2Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Usage52
- Downloads38
- Abstract Views14
- Captures2
- Readers2
Article Description
Background: Current guidelines for acute ST-segment elevation myocardial infarction (STEMI) patients declared primary percutaneous coronary intervention (PPCI) as the mainstay reperfusion strategy. However, the no-reflow phenomenon(NRP) is a major drawback. The longer ischemia lasts, the more likely NRP is to occur causing more myocardial cells damage.Aim of the Work: to correlate between the CHA2DS2VAScHS score and NPR in patient presented with STEMI and treated with PPCI.Methods: Case-control study that included one hundred patients presented with STEMI and treated with PPCI. Patients were further divided into group(A) in which patients developed no-reflow (NR) after PPCI and group(B) in which patients achieved TIMI-III flow after PPCI. CHA2DS2VAScHS score was calculated for every patient.Results: The study showed an increase in no-reflow in patients with higher CHA2DS2VAScHS score and no-reflow in STEMI patients treated with PPCI (p-value:0.000).Conclusion: CHA2DS2VAScHS score is effective in the early prediction of NPR in patients with STEMI patients managed with PPCI.
Bibliographic Details
Al-Azhar University
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know